Roche

Netupitant Results Could Roil Tesaro In May

Netupitant Results Could Roil Tesaro In May

Seeking Alpha

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Motley Fool

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial

Seeking Alpha

Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval

Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval

Seeking Alpha

Roche to shed 170 jobs in diagnostics restructuring

Roche to shed 170 jobs in diagnostics restructuring

Reuters

Moody's sees pick-up in pharmaceutical industry M&A in 2013

Moody's sees pick-up in pharmaceutical industry M&A in 2013

Reuters

Top 10 pharma companies by employees

Top 10 pharma companies by employees

Fierce Pharma

3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak

3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak

Seeking Alpha

Roche in hepatitis C drug deal with Ascletis in China

Roche in hepatitis C drug deal with Ascletis in China

Reuters

Firm ranks top 5 biotech deals in evolving pharma R&D landscape

Firm ranks top 5 biotech deals in evolving pharma R&D landscape

Fierce Biotech